DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63α from Dimer to Tetramer
TAp63α, a homolog of the p53 tumor suppressor, is a quality control factor in the female germline. Remarkably, already undamaged oocytes express high levels of the protein, suggesting that TAp63α's activity is under tight control of an inhibitory mechanism. Biochemical studies have proposed tha...
Saved in:
Published in | Cell Vol. 144; no. 4; pp. 566 - 576 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
18.02.2011
Cell Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | TAp63α, a homolog of the p53 tumor suppressor, is a quality control factor in the female germline. Remarkably, already undamaged oocytes express high levels of the protein, suggesting that TAp63α's activity is under tight control of an inhibitory mechanism. Biochemical studies have proposed that inhibition requires the C-terminal transactivation inhibitory domain. However, the structural mechanism of TAp63α inhibition remains unknown. Here, we show that TAp63α is kept in an inactive dimeric state. We reveal that relief of inhibition leads to tetramer formation with ∼20-fold higher DNA affinity. In vivo, phosphorylation-triggered tetramerization of TAp63α is not reversible by dephosphorylation. Furthermore, we show that a helix in the oligomerization domain of p63 is crucial for tetramer stabilization and competes with the transactivation domain for the same binding site. Our results demonstrate how TAp63α is inhibited by complex domain-domain interactions that provide the basis for regulating quality control in oocytes.
[Display omitted]
► TAp63α is inhibited in a dimeric state by complex domain-domain interactions ► Phosphorylation-triggered TAp63α activation upon DNA damage requires tetramerization ► Tetramer stabilization requires the second helix H2 of the tetramerization domain ► Tetramerization domain binding by the transactivation domain is competed by helix H2 |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.cell.2011.01.013 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 These authors contributed equally to this work |
ISSN: | 0092-8674 1097-4172 |
DOI: | 10.1016/j.cell.2011.01.013 |